ClinicaliQ Trial Snapshot
- A Study to Evaluate the Performance of Confocal Microscopy to Detect Positive Margins During Radical Prostatectomy — Recruiting • Non-phase study • Oncology • NCT07541911.
- Technology Being Tested: LaserSAFE confocal microscopy is being evaluated for its ability to accurately detect positive surgical margins (cancer cells at the edge of resected prostate tissue) in real-time during radical prostatectomy procedures.
- Patient Eligibility: The study includes men undergoing radical prostatectomy for prostate cancer; specific inclusion criteria regarding disease stage, risk stratification, and PSA levels should be confirmed in the full protocol documentation.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
The goal of this study is to find out whether a new method called "LaserSAFE" can accurately detect cancer at the edge of the prostate (called a positive margin) during prostate surgery. LaserSAFE uses a special microscope in the operating room to quickly scan the prostate after it has been removed from the body. This information can help surgeons decide whether it is safe to preserve the nerves around the prostate. This is especially important for patients who are not usually considered suitable for nerve-sparing surgery using current methods. The…
Eligibility Snapshot
- : * Patients diagnosed with clinically significant operable cT2-T3a N0 M0 PC. * Medically fit to undergo RARP. * Scheduled for robot-assisted RARP with a recommendation against intrafascial nerve sparing on at least 1 side based on multidisciplinary meetings informed by MRI, biopsy result and clinical factors. * Ability to read English sufficiently to understand PIS and able to give informed consent.
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.